Global pharmaceutical company Zydus Cadila and Pieris, a therapeutic protein research and development company, have entered into an alliance for development and commercialization of multiple novel Anticalin-based protein therapeutics. The ...
Refining capacity expansions in China have been largely on track this year although the country's relatively weaker growth in oil demand could delay some projects and result in lower utilization rates, analysts said this week. Up to 1.3 ...
Tags: oil, Metallurgy, Mineral
Accsys Technologies, the parent firm of the Accoya wood producer Titan Wood, cancelled a production and distribution licence for Accoya wood that Diamond Wood had held since 2007. The licence agreement entailed construction of an Accoya ...
Tags: Construction, wood
The European Commission has approved Regeneron Pharmaceuticals's Eylea (aflibercept) injection for the treatment of visual impairment caused by macular edema secondary to central retinal vein occlusion (CRVO). Eylea is a recombinant ...
Tags: fusion protein, Eylea
Symphony Environmental Technologies Plc, global specialists in advanced plastics and tyre recycling technologies, is pleased to announce that it has signed a five year supply and marketing agreement with Janssen Pharmaceutica, a division of ...
Cornerstone Therapeutics has signed an agreement to acquire exclusive US marketing rights to Pertzye (pancrelipase) from Digestive Care (DCI). Pertzye, the pancreatic enzyme product, is indicated for the treatment of exocrine pancreatic ...
Tags: Cornerstone, Digestive Care
Specialty pharmaceutical company Nuvo Research has announced the launch of Pliaglis (lidocaine and tetracaine) cream 7%/7% by Galderma in Europe. Galderma has worldwide marketing rights for Nuvo's Pliaglis, a topical local anesthetic ...
Tags: Nuvo Research, Pliaglis
SK Biopharmaceuticals and SK Chemicals, both part of the SK Group, have signed a co-development agreement for YKP10811 to treat irritable bowel syndrome with constipation (IBS-C). Under the deal, SK Chemicals will carry out later-stage ...
US-based medical technology company Medtronic has secured US marketing rights for its Affinity Fusion oxygenation system following the regulatory approval from the US Food and Drug Administration (FDA). The CE-marked system, which serves ...
Tags: FDA, Fusion Oxygenation System
The US food and drug administration (FDA) has approved Janssen's Invokana (canagliflozin) for the treatment of adults with type 2 diabetes. Invokana is the oral, once-daily medication available in the US demonstrating improved glycemic ...
Effective April 1 Mitsubishi Heavy Industries, Ltd. (MHI) and Imabari Shipbuilding Co., Ltd. of Imabari, Ehime Prefecture, will jointly establish MI LNG Company, Limited, a company to handle the design and marketing of LNG (liquefied ...
Tags: MHI, Imabari Shipbuilding, Transportation
On-X Life Technologies has gained US marketing rights to its new On-X aortic prosthetic valve with anatomic sewing ring, following the regulatory approval from the US Food and Drug Administration (FDA). The prosthetic valve, which is made ...
Food and Drug Administration (FDA) has approved US-based pharmaceutical company Shionogi's Osphena (ospemifene) tablets for the treatment of moderate to severe dyspareunia (painful intercourse), a symptom of vulvar and vaginal atrophy ...
Tags: FDA, Dyspareunia, Medicine
Medtronic has gained US marketing rights for new sizes of its Resolute Integrity drug-eluting stent, following the regulatory approval from the Food and Drug Administration (FDA). Available in 34mm, 38mm lengths and 3.0mm, 3.5mm and 4.0mm ...
Galderma Laboratories has gained US marketing rights for its Epiduo (adapalene 0.1%/BPO 2.5%) Gel, designed for the treatment of acne in children as young as nine years old, following the approval from the US Food and Drug Administration ...